Skip to navigation Skip to content



National MS Society-Supported Studies Highlighted Among Journal’s Top Picks For Progress In MS

January 6, 2015

Lancet Neurology picked its top choices for studies published during 2014. Among them are:

  • A study from the University College of London and other institutions suggesting that a particular gene may influence nervous system injury in people with the primary progressive form of MS;
  • A study by a team at the University of California, Los Angeles, suggesting that sex chromosomes may influence the degree of nervous system injury from immune attacks in mice (funded by the National MS Society); and
  • A recent effort to fine-tune descriptions of MS by the International Advisory Committee on Clinical Trials in MS, jointly supported by the National MS Society and the European Committee for Treatment and Research in MS. 

Read the full article in Lancet Neurology (open access with free registration) 
Read more highlights of 2014 MS research progress   

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.